1. Introduction {#sec1-molecules-25-03376}
===============

Copper is an essential element for life as it is incorporated into a variety of proteins and metalloenzymes, which occur in animals and plants and required to perform essential metabolic functions. Many of biologically active copper enzymes are utilized for electron transfer reactions, oxygen transport and oxygenation reactions \[[@B1-molecules-25-03376],[@B2-molecules-25-03376]\]. The deficiency in copper or its high concentration in human tissues may lead to Menkes or Wilson diseases, respectively \[[@B3-molecules-25-03376]\]. Over the last decade, a wide range of copper(II) complexes were demonstrated to be potentially effective as anticancer agents \[[@B4-molecules-25-03376],[@B5-molecules-25-03376],[@B6-molecules-25-03376],[@B7-molecules-25-03376],[@B8-molecules-25-03376]\] and less toxic compared to the currently used platinum-based anticancer drugs \[[@B9-molecules-25-03376]\]. Many of the designed anticancer Cu(II) are coordination compounds containing polyamines as coligands and chloride or bromide groups \[[@B5-molecules-25-03376],[@B6-molecules-25-03376],[@B7-molecules-25-03376],[@B8-molecules-25-03376],[@B10-molecules-25-03376],[@B11-molecules-25-03376],[@B12-molecules-25-03376]\]. In some cases, these halido compounds are unstable in solutions and may undergo solvolysis or aquation with possible stereochemical geometry change \[[@B5-molecules-25-03376],[@B7-molecules-25-03376],[@B11-molecules-25-03376],[@B12-molecules-25-03376]\].

The interaction of pseudohalides (isothiocyanate, NCS^−^; azide, N~3~^−^; and dicyanamide, dca) with Cu(II) salts in the presence of coligands resulted in the construction of polynuclear compounds with different dimensionality and nuclearity, and coordination polymers (CPs) with diverse topology \[[@B13-molecules-25-03376],[@B14-molecules-25-03376],[@B15-molecules-25-03376],[@B16-molecules-25-03376],[@B17-molecules-25-03376],[@B18-molecules-25-03376],[@B19-molecules-25-03376]\]. This was attributed to the high ability of the pseudohalide ions to act as bridging ligands in a variety of bonding modes and mediating the magnetic interaction between Cu^2+^ centers \[[@B17-molecules-25-03376],[@B18-molecules-25-03376],[@B19-molecules-25-03376],[@B20-molecules-25-03376]\], where efficient magnetic transmitting was found in case of the azide bridging compounds \[[@B17-molecules-25-03376],[@B19-molecules-25-03376],[@B20-molecules-25-03376]\]. However, mononuclear pseudohalido-Cu(II) complexes are known to be formed too \[[@B21-molecules-25-03376],[@B22-molecules-25-03376],[@B23-molecules-25-03376],[@B24-molecules-25-03376],[@B25-molecules-25-03376],[@B26-molecules-25-03376],[@B27-molecules-25-03376],[@B28-molecules-25-03376],[@B29-molecules-25-03376],[@B30-molecules-25-03376]\] and are very stable in aqueous and common organic solvents \[[@B27-molecules-25-03376],[@B28-molecules-25-03376]\]. The Cu(II) centers in these compounds display variable geometries ranging from four---(square planar and tetrahedral) to six---(octahedral) as well as five-coordinated species. The latter species exist in solutions in equilibrium between the square pyramidal (SP) and trigonal bipyramidal (TBP) geometries as the energy barrier between the two species is very small \[[@B31-molecules-25-03376]\]. Several structural parameters such as steric effect, nature of the chelate ring size (ligand bite) and skeleton of the coordinated coligand were proposed to account for the presence of specific predominant stereochemical geometry \[[@B22-molecules-25-03376],[@B23-molecules-25-03376],[@B24-molecules-25-03376]\]. Taking into considerations the stability of the pseudohalido- vs. instability of some halido-copper(II) complexes, it is safe to point out that molecular structures do not always provide information about how these halido complexes exist in solution, especially if the halido-Cu(II) compounds persist in solutions \[[@B5-molecules-25-03376],[@B7-molecules-25-03376]\].

Thus, in order to investigate the above parameters that influence the geometry of the five-coordinated Cu(II) species, a novel series of mononuclear pseudohalide complexes derived from *N*-donors tri- and tetra-dentate amines with different coligand skeletons were synthesized. These include: \[Cu(L^1^)(NCS)~2~\] (**1**), \[Cu(L^2^)(NCS)~2~\] (**2**), \[Cu(isp~3~tren)(N~3~)\]ClO~4~ (**3**), \[Cu(isp~3~tren)(dca)\]ClO~4~ (**4**), \[Cu(L^3^)(NCS)\]ClO~4~ (**5**), \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O (**6**) and \[Cu(L^4^)(dca)\](ClO~4~)∙2H~2~O (**7**) complexes, where L^1^ = \[(2-pyridyl)-2-ethyl)-(3,4-dimethoxy)-2-methylpyridyl\]methylamine, L^2^ = \[(2-pyridyl)-2-ethyl)-(3,5-dimethyl-4-methoxy)-2-methylpyridyl\]methylamine, L^3^ = bis(2-ethyl-di(3,5-dimethyl-1*H*-pyrazol-1-yl)-\[2-(3,4-dimethoxypyridylmethyl)\]amine, L^4^ = bis(2-methylpyridyl)-\[2-(3,4-dimethoxypyridyl-methyl)\]amine, isp~3~tren = tris\[(2-isopropylamino)ethyl)\]amine and tedmpza = tris\[(2-(3,5-dimethyl-1*H*-pyrazol-1-yl)ethyl\]amine ([Scheme 1](#molecules-25-03376-sch001){ref-type="scheme"}). The molecular structures of these complexes were determined and analyzed as function of the index distortion parameters τ and correlated to the assigned geometries, which were derived from their visible electronic spectra in solutions. The results are discussed and compared to other related pseudohalido as well as halido compounds in an attempt to predict the predominant five-coordinated geometry in solution and for how far one can rely on this geometrical assignment.

2. Results and Discussion {#sec2-molecules-25-03376}
=========================

2.1. Synthetic Aspects {#sec2dot1-molecules-25-03376}
----------------------

The interaction of methanolic solutions containing Cu(ClO~4~)~2~·6H~2~O or Cu(NO~3~)~2~·3H~2~O with the tridentate amines L^1^ or L^2^ ([Scheme 1](#molecules-25-03376-sch001){ref-type="scheme"}) in the presence of NH~4~NCS and the stoichiometric ratios 1:1:1 or 1:1:2 afforded the mononuclear diisothiocyanato complexes \[Cu(L^1^)(NCS)~2~\] (**1**) and \[Cu(L^2^)(NCS)~2~\] (**2**), respectively, whereas the reaction of Cu(ClO~4~)~2~·6H~2~O with the tripod tetraamine ligand, L^3^ resulted in the formation of \[Cu(L^3^)(NCS)\]ClO~4~ (**5**). Similarly, bluish green complexes \[Cu(isp~3~tren)(dca)\]ClO~4~ (**4**), \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O (**6**), and \[Cu(L^4^)(dca)\](ClO~4~)·2H~2~O (**7**) were obtained from the reactions of methanolic solutions containing Cu(ClO~4~)~2~·6H~2~O and the corresponding tripod ligands isp~3~tren, tedmpza and L^4^ ([Scheme 1](#molecules-25-03376-sch001){ref-type="scheme"}) respectively, with an aqueous solution of Nadca in a 1:1:1 or even 1:1:2 molar ratios. The green azido complex, \[Cu(isp~3~tren)(N~3~)\]ClO~4~ (**3**) was obtained using a similar procedure as that described for the dicyanamido complexes. The isolated complexes were produced in moderate to excellent yields (60--95%).

Single crystals suitable for X-ray analysis were obtained either from dilute aqueous-methanol solutions (**3**, **4**) or recrystallization (CH~3~CN: **1**, **2**; CH~3~OH: **6**; and H~2~O: **5**). Attempts made to get good crystals of complex **7** failed. All the complexes were characterized by elemental microanalyses, IR and UV-vis spectra and molar conductivity measurements (Λ~M~ in acetonitrile solutions) as well as X-ray single crystals crystallography for complexes **1**--**6**. The molar conductivity of the complexes **3**--**7** were found to be in the range 147--163 Ω^−1^·cm^2^·mol^−1^, which are in complete agreement with the predicted formulas as 1:1 electrolytic nature \[[@B32-molecules-25-03376]\]. On the other hand, \[Cu(L^1^)(NCS)~2~\] (**1**) and \[Cu(L^2^)(NCS)~2~\] (**2**) complexes produced Λ~M~ values of 9 and 11 Ω^−1^·cm^2^·mol^−1^, respectively. These values are fully consistent with their non-electrolytic behavior \[[@B32-molecules-25-03376],[@B33-molecules-25-03376]\]. The complexes are soluble in CH~3~CN and CH~3~OH and their solution electronic or molar conductivity, which were measured over four days did not show any sign of solvolysis, geometrical changes, nor degradation.

2.2. IR Spectra of the Complexes {#sec2dot2-molecules-25-03376}
--------------------------------

The IR spectra of the isothiocyanato compounds **1**, **2** and **4** display a strong stretching vibration at 2055, 2054, and 2091 cm^−1^ respectively, corresponding to the ν~as~(C≡N) frequency. This is most likely consistent with *N*-bonded isothiocyanate, which in general shows ν~as~ \< 2110 cm^−1^, whereas the corresponding *S*-bonded isothiocyanate bonding mode reveals the ν~as~(C≡N) at higher frequencies (\>2110 cm^−1^) \[[@B23-molecules-25-03376],[@B24-molecules-25-03376],[@B34-molecules-25-03376],[@B35-molecules-25-03376],[@B36-molecules-25-03376]\]. The azido complex **3** displays a single very strong absorption band at 2055 cm^−1^ due to the asymmetric stretching vibration, ν~as~(N~3~) of the coordinated mono-dentate azido group \[[@B18-molecules-25-03376],[@B26-molecules-25-03376],[@B29-molecules-25-03376]\]. Three strong bands were detected over the frequency region 2350--2170 cm^−1^ for the dicyanamido complexes **4** and **6** being comparable to those observed in the free dicyanamide stretching frequencies \[ν~as~ + ν~sym~(C≡N)\] 2286 cm^−1^, ν~as~(C≡N) 2232 cm^−1^ and ν~sym~(C≡N) 2179 cm^−1^ \[[@B37-molecules-25-03376]\] and indicating monodentate *N*-nitrile dca \[[@B27-molecules-25-03376],[@B28-molecules-25-03376],[@B29-molecules-25-03376]\]. However, we should mention that the dicyanamido complex **7** displayed four strong bands for the coordinated dca at 2300, 2236, 2176, and 2137 cm^−1^. In addition the compounds **3**--**7** reveal a single strong band over the range 1100--1070 cm^−1^ attributable to the ν(Cl-O) stretching vibration of the perchlorate counter ion. The split of this band (1090 and 1067 cm^−1^) in **7** is probably due to the reduction of the ClO~4~^−^ symmetry from T~d~ to C~3υ~ or C~2υ~. The water of crystallization in \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O (**6**) and \[Cu(L^4^)(dca)\]ClO~4~·2H~2~O (**7**) was detected as a broad band at 3448 and 3435 cm^−1^ respectively, due to ν~as~(O-H) stretching frequency.

2.3. Description of the Structures {#sec2dot3-molecules-25-03376}
----------------------------------

### 2.3.1. \[Cu(L^1^)(NCS)~2~\] (**1**), \[Cu(L^2^)(NCS)~2~\] (**2**) and \[Cu(L^3^)(NCS)\]ClO~4~ (**5**) {#sec2dot3dot1-molecules-25-03376}

The isothiocyanate compounds **1** and **2** form neutral monomeric complexes, whereas **5** crystallizes as a mononuclear complex cation together with perchlorate counter anion. In **1** and **2**, the Cu(II) centers are ligated by two terminal *N*-coordinated NCS^−^ anions and three donor *N*-atoms of the tri-dentate amine ligands L^1^ and L^2^, respectively, while in complex cation of **5**, the Cu(II) center is ligated by one terminal *N*-coordinated NCS^−^ anion and four donor *N*-atoms of the tetra-dentate amine ligand L^3^ ([Figure 1](#molecules-25-03376-f001){ref-type="fig"}). The CuN~5~ chromophores of the metal centers exhibit distorted and slightly elongated square pyramidal (SP) geometry with τ-values of 0.08 for **1**, 0.14 for **2**, and 0.02 for **5** \[[@B38-molecules-25-03376]\]. In the neutral complexes the apical position is occupied by *N*-NCS^−^, with Cu-N apical bond distances of 2.188(2) and 2.165(7) Å, for **1** and **2**, respectively, whereas in **5** the apical position is occupied by N4 of the tetra amine L^3^ ligand \[Cu-N4 = 2.232(3) Å\]. The basal Cu-N bond lengths in the three compounds vary from 1.955(3) to 2.087(3) Å. The central N(amine) donor atoms of L^1^, L^2^, and L^3^ molecules, respectively, are placed trans to the basal *N*-(NCS) anions, which have the shortest Cu-N bonds \[1.955(3)--1.988(6) Å\]. The terminal NCS^−^ anions have the following bond parameters: N-C: 1.153(3)--1.163(10) Å; C-S: 1.626(4)--1.649 Å; Cu-N-C 149.0(2)--175.0(3)°; N-C-S: 177.9(7)--179.5(4)°.

### 2.3.2. \[Cu(isp~3~tren)(N~3~)\]ClO~4~ (**3**), \[Cu(isp~3~tren)(dca)\]ClO~4~ (**4**), and \[Cu(tedmpza)(dca)\]ClO~4~∙0.67H~2~O (**6**) {#sec2dot3dot2-molecules-25-03376}

The mononuclear \[Cu(isp~3~tren)(X)\]^+^ complex cations, \[X = N~3~ for **3** and dca for **4**\] co-crystallize with ClO~4~^−^ counter anions. Three crystallographic independent \[Cu(tedmpza)(dca)\]^+^ cations with three ClO~4~^−^ counter anions and two solvent water molecules are located in the triclinic unit cell of **6**. Each Cu(II) center in compounds **3**, **4**, and **6** is ligated by one terminal *N*-coordinated pseudohalide anion and four *N*-donor atoms of the tetra-dentate amine ligands (isp~3~tren or tedmpza) ([Figure 2](#molecules-25-03376-f002){ref-type="fig"}). The CuN~5~ chromophores of the copper centers exhibit slightly distorted trigonal bipyramidal (TBP) geometry with τ-values of 0.78 for **1**, 0.77 for **2**, and 0.78, 0.89, and 0.82 for Cu1-Cu3 of **6**, respectively \[[@B38-molecules-25-03376]\]. The axial positions are occupied by one *N*-terminal pseudohalide anion and the central N(amine) donor atom of the tetra-dentate molecules, whereas the equatorial positions are occupied by three *N*-donor atoms of the arms of the isp~3~tren or tedmpza molecules. The shortest bond distances within each CuN~5~ polyhedron are observed for the Cu-N(N~3~) \[1.9735(17) Å\] and Cu-N(dca) \[from 1.951(6) to 1.971(5) Å\], while the axial Cu-N(amine) bond distances are in the range from 2.041(3) to 2.097(5) Å. The equatorial Cu-N bond lengths vary from 2.043(6) to 2.2417(17) Å. The terminal azide anion in **3** has N5-N6 and N6-N7 bond distances of 1.193(3) and 1.163(5) Å, and Cu-N5-N6 and N5-N6-N7 bond angles of 130.37(14) and 176.3(2)°, respectively. The terminal dca anions in **4** and **6** have the following bond parameters: C-N(nitrile): from 1.107(10) to 1.162(8) Å; C-N(amine): from 1.290(9) to 1.339(11) Å; Cu-N-C: from 162.5(7) to 173.6(6)°; N-C-N: from 163.5(9) to 175.9(8)°, and C-N-C: from 116.1(8) to 122.1(4)°.

In **6**, the three complex cations differ mainly in the torsion around the dca ligation \[torsion angles: Cu1-N8···N9···N10 = −116.87°; Cu2-N18···N19···N20 = 47.37°; Cu3-N28···N29···N30 = 104.94°\]. Furthermore, only dca donor atom N30 of complex cation of Cu3 is involved in a hydrogen bond of type O-H···N to water molecule O13, which forms also a hydrogen bond of type O-H···O to perchlorate counter anion of Cl2. The second water molecule O14 forms only hydrogen bonds of type O-H···O to water molecule O13 and perchlorate counter anion of Cl3 (see packing plot [Figure S6](#app1-molecules-25-03376){ref-type="app"}, and [Table S4](#app1-molecules-25-03376){ref-type="app"}, [Supplementary Materials](#app1-molecules-25-03376){ref-type="app"}).

2.4. UV-Vis Spectra of the Complexes {#sec2dot4-molecules-25-03376}
------------------------------------

The acetonitrile electronic spectra of the Cu(II) complexes **1**--**7** can be classified into two categories:

\(1\) Complexes **1** and **2**, which were derived from tridentate ligands L^1^ and L^2^ exhibit a single broad absorption around 676 nm.

\(2\) Complexes **3**--**7** revealed a shoulder or relatively weak band over the region 630--740 nm and a broad band over the wavelength region 840--940 nm.

In addition, the very strong intense band located around 390 nm for compounds **1**, **2**, **5** and **6**, and at 350 nm in **7** can be assigned to ligand-metal charge transfer transition (LMCT). The visible spectral features observed in the two categories of complexes are consistent with five-coordinated Cu(II) geometries. In general, Cu^2+^ in square pyramidal geometry (SP) exhibits broad band in the visible region (590--780 nm), which occasionally may or may not be associated with a low-energy shoulder at λ \> 800 nm (spin forbidden), whereas trigonal bipyramidal (TBP) are known to display a single *d-d* band at λ \> 800 nm with a high-energy shoulder in the visible region \[[@B39-molecules-25-03376]\]. Therefore, based on this criterion, the acetonitrile visible spectral data of the complexes under investigation are consistent with SP geometry in complexes **1** and **2** \[[@B25-molecules-25-03376],[@B40-molecules-25-03376]\], whereas TBP environment seems to be dominating in the second category of complexes **3**--**7** coordinated to tripodal tetraamine coligands (L^3^, L^4^, isp~3~tren, tedmpza; [Scheme 1](#molecules-25-03376-sch001){ref-type="scheme"}) \[[@B41-molecules-25-03376]\]. It is important to point out that the intensity of band at λ \> 800 nm in TBP geometries should be higher than the shoulder or the band located at λ \< 800 nm (small intense maxima). However, it should be emphasized that in most cases, the complexes may exhibit intermediate geometries which are slightly distorted from the ideal SP or TBP.

2.5. Molecular vs. Solution Structures in Five-Coordinated Cu(II) Complexes {#sec2dot5-molecules-25-03376}
---------------------------------------------------------------------------

Five-coordinated metal(II) complexes, especially when the central metal ion is Cu(II), Co(II), or Zn(II) are quite known to crystallize in two stereochemical environments around the central M^2+^ ion namely square pyramidal (SP) and trigonal bipyramidal (TBP) ([Figure 3](#molecules-25-03376-f003){ref-type="fig"}) because the energy barrier between the two possible limiting geometries is rather small \[[@B32-molecules-25-03376]\]. Several factors were considered to contribute to this phenomenon such as the nature of the central metal ion, chelate ring size, and coligand's skeleton as well as the steric substituent effect incorporated into its structure. These factors play crucial roles in adopting one of the two geometries. From the molecular structure point of view, it is possible to quantify the extent of distortion of the metal polyhedron through the evaluation of the structural index parameter (τ), which is defined as the ratio between the two basal angles θ and ϕ in the given five-coordinated complex, τ = (θ − ϕ)/60, where θ ≥ ϕ. A perfect TBP is associated with ϕ = 120° and θ = 180°, leads to τ = 1, whereas in an ideal SP geometry θ = ϕ = 180° leading to τ = 0 \[[@B38-molecules-25-03376]\]. In real SP structures, the metal ion is always located out of the equatorial plane towards the axial bond and the resulting C~4υ~ geometry is still be characterized by τ ≈ 0 (θ ≈ ϕ \< 180°). In the solid state, one of the two conformations is isolated as a predominant geometrical isomer. However, in solutions the situation is different and it is not necessary that the molecular structure, which isolated persists in solution.

This section is devoted to consider the molecular and solution structures of the mononuclear pseudohalide-Cu(II) five-coordinated complexes **1**--**6** together with some other related compounds, which are also mononuclear and their structures were determined in both the solid and solution states. This comparison will allow us to analyze the structural parameters leading to the isolation of a specific geometrical conformation (TBP vs. SP). Therefore, a number of these compounds were compiled in [Table 1](#molecules-25-03376-t001){ref-type="table"} together with their corresponding τ values. Furthermore, the visible spectra of the same series of compounds in solutions are collected in [Table 2](#molecules-25-03376-t002){ref-type="table"}. Comparing the molecular and solution structures should provide some information about the validity of the predicted geometry in solutions and to what extent one can rely on the structural results in solutions.

Inspection of the data given in [Table 1](#molecules-25-03376-t001){ref-type="table"} reveals that five-coordinated isothiocyanato-Cu(II) complexes **1**, **2** and **8**--**20**, which were derived from linear tridentate, tripodal tetra- or cyclic-tetradentate (cyclen-tmpa) ligands show very high tendency to adopt SP geometry regardless the chelate ring sizes (five or six). In contrast, the corresponding azido **3**, **25**, and **27**, and the dicyanamido series **4**, **8**, and **36** constructed from tripodal tetradentate ligands with all compounds displaying five-membered chelate rings (tren, Me~3~tren, isp~3~tren, TPA) indicate more preference for TBP geometry. This stereochemical structure changes to SP as the number of six-membered rings increases as this was the case on going from TPA (complexes **27** and **36** with τ values of 0.91 and 0.95, respectively) to pmap or tepa in compounds **30** and **37** as well as in \[Cu(tedmpza)(N~3~)\]ClO~4~ (**31**) or from tren to trpn in complexes **35** and **32**, respectively. Most likely this is attributed to the flexibility of the six-membered chelate rings. Similar SP geometry was also observed when steric effect at the coordinated amines are fully alkylated as in \[Cu(pmedien)(dca)~2~\] (**33**). Moreover, moderate substituents into the pyridyl groups of TPA, especially at position 6 results in increasing the distortion of the TBP geometry observed in TPA complexes (see complexes **28**: τ = 0.65 and **29**: τ = 0.65 and 0.73; 0.68; 0.50; 0.61; 0.31, \[[@B47-molecules-25-03376]\]). However, we should mention that some pronounced deviations were found in the azido compound **31** and its corresponding dicyanamido, \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O (**6**) and in related tris pyrazolyl, \[Cu(tepza)(dca)\]ClO~4~ (**38**) (based on the above analysis both are expected to exhibit SP). These deviations may result from the crystal packing.

Transferring the compound of which its molecular structure was determined into solution is a complicated issue due to possible solvolysis, stereochemical change or decomposition of the complex. The question now which class of compounds can retain their geometries in solutions? To provide a satisfactory answer to this question, the solution visible electronic spectra of the compounds shown in [Table 1](#molecules-25-03376-t001){ref-type="table"} are collected in [Table 2](#molecules-25-03376-t002){ref-type="table"} with predicted predominant geometries based on the analysis provided in [Section 2.4](#sec2dot4-molecules-25-03376){ref-type="sec"}. Probably, we should mention that the complexes **1**--**7** were shown to be very stable in common organic solvents for several days. Similar behavior was also reported in complexes \[Cu(trpn)(N~3~)\]ClO~4~ (**32**), \[Cu(tepa)(dca)\]ClO~4~ (**37**), and \[Cu(tren)(dca)\]ClO~4~ (**35**) \[[@B27-molecules-25-03376],[@B28-molecules-25-03376],[@B48-molecules-25-03376]\].

Inspection of the data in [Table 2](#molecules-25-03376-t002){ref-type="table"}, and the corresponding molecular structures given in [Table 1](#molecules-25-03376-t001){ref-type="table"}, surprisingly indicate complete agreement between the predicted geometries in solution and the molecular structures. This finding means we can rely with confidence that the determined molecular structures in five-coordinated pseudohalido-Cu(II) complexes are retained in solutions without any stereochemical change.

Since many of the halido-Cu(II) complexes are now extensively used to mimic biological systems, especially those derived from tripodal and linear tetraamine coligands (N4), \[Cu(N4)X\]^+^ in DNA cleavage and the cytotoxicity studies as potential anticancer agents \[[@B4-molecules-25-03376],[@B5-molecules-25-03376],[@B6-molecules-25-03376],[@B7-molecules-25-03376],[@B8-molecules-25-03376],[@B49-molecules-25-03376],[@B50-molecules-25-03376],[@B51-molecules-25-03376],[@B52-molecules-25-03376]\], it is worthwhile to shed the light on the behavior of this class of compounds in solutions in order check the validity of geometrical structures at the two levels. The data compiled in [Table 3](#molecules-25-03376-t003){ref-type="table"} reveals that increasing the steric crowding at the TPA through successive methylation at the 6th position of the pyridyl groups resulted in the conversion from perfect TBP geometry as in \[Cu(TPA)Cl\]^+^ to distorted SP in \[Cu(6-MeTPA)Cl\]^+^ and \[Cu(6-Me~2~TPA)Cl\]^+^, and to intermediate geometry in the most sterically hindered \[Cu(6-Me~3~TPA)Cl\]^+^ complex ion ([Table 3](#molecules-25-03376-t003){ref-type="table"}: compounds **42**--**46**), a result which was unexpected. Probably, this behavior was enhanced when more substituents were incorporated into the TPA-pyridyl group as this was seen in complexes **55**--**58**, where the TBP is becoming more stabilized \[[@B8-molecules-25-03376]\]. The same trend was observed in the quinolyl derivatives of TPA: \[Cu(BPQA)Cl\]^+^ and \[Cu(BQPA)Cl\]^+^, where geometry changes to dist. SP and then to dist. TBP in the latter case (compounds **51**--**54**). Moreover, SP geometries seem to be the most preferable species with bidentate (L^9^), linear tri-(L^8^) and tetra-dentate (L^10^) ligands as these were the cases of complexes **61**--**63** \[[@B49-molecules-25-03376],[@B50-molecules-25-03376],[@B51-molecules-25-03376]\].

On the other hand, Cu(II) complex ions with only five-membered chelate ring size adopt almost perfect TBP geometry as it was demonstrated in \[Cu(TPA)X\]^+^ (X = Cl, F) (**39**--**41**) and \[Cu(Me~6~tren)X\]^+^ (X = Cl, Br); (**59**, **60**) \[[@B52-molecules-25-03376],[@B53-molecules-25-03376],[@B54-molecules-25-03376],[@B58-molecules-25-03376]\] and dramatic shift to almost perfect SP was observed when six-membered chelate rings were employed, \[Cu(N4)Cl\]^+^ (N4 = pmea, pmap, tepa: **48**--**51**) \[[@B56-molecules-25-03376],[@B57-molecules-25-03376]\]. This trend is similar and more pronounced in this series compared to those observed above in the corresponding pseudohalide species.

Although data compiled in [Table 3](#molecules-25-03376-t003){ref-type="table"} for the assigned geometry in solutions shows that the agreement of the molecular and solution structures is not bad in most cases, results must be considered with caution due to possible geometrical changes in some cases such as in \[Cu(6-MeTPA)Cl\]^+^ (**42** and **43**) and \[Cu(BPQA)Cl\]^+^ (**51** and **52**) \[[@B8-molecules-25-03376],[@B55-molecules-25-03376]\]. In addition, it has been reported that some (Cu(II) complexes are unstable in organic solvents or aqueous media and may undergo solvolysis/aquation as this was evidenced in complex \[Cu(L^9^)Cl~2~\] (**61**). The conductance measurements of this compound showed that it is non-conducting in dry DMF, DMSO, and CH~3~CN as this was expected from its molecular formula but in MeOH and aqueous/DMF solutions, the complex displayed both 1:1 and 1:2 electrolytic behaviors, respectively indicating the loss of chloride ligand(s) and the formation of \[Cu(L^9^)Cl(H~2~O)\]^+^ and \[M(L^9^)(H~2~O)~2~\]^2+^ species \[[@B49-molecules-25-03376]\]. Similar behaviour was also observed in \[Cu(L^10^)(H~2~O)(Cl)~2~\] (**62**) and \[Cu(L^11^)(Br)~2~\] (**63**) complexes \[[@B50-molecules-25-03376],[@B51-molecules-25-03376]\].

3. Materials and Methods {#sec3-molecules-25-03376}
========================

3.1. Materials and Physical Measurements {#sec3dot1-molecules-25-03376}
----------------------------------------

*N*-Methyl-*N*-(2-pyridyl)ethyl)amine was purchased from Maybridge, Belgium and tris\[(2-isoptopylamino)ethyl)\]amine from Aldrich. 3,4-Dimethoxy-2-chloromethylpyridine, 3,5-dimethyl-4-methoxy)-2-chloromethylpyridine, bis(2-methylpyridyl)amine, bis(2-chloroethyl)-amine and 3,5-dimethylpyrazole were purchased from TCI-America (Portland, OR, USA). All other materials were reagent grade quality. Infrared spectra were recorded on a Cary 630 (ATR) spectrometer (Santa Clara, CA, USA) or JASCO FT/IR-480 plus spectrometer (Oklahoma City, OK, USA) using KBr pellets. Electronic spectra were recorded using Agilent 8453 HP diode UV-vis Spectrophotometer (Santa Clara, CA, USA). The molar conductivity of a solution sample was determined from Λ~M~ = (1.0 × 10^3^ κ)/\[Cu\], where κ is the specific conductance and \[Cu\] is the molar concentration of the complex. The measurements were performed using Mettler Toledo Seven Easy conductometer (Columbus, OH, USA) and calibration was determined by the aid of 1413 μS/cm conductivity standard. Elemental microanalyses were carried out by Atlantic Microlaboratory (Norcross, GA, USA).

**Caution**! Salts of perchlorate and azide as well as their metal complexes are potentially explosive and should be handled with great care and in small quantities.

3.2. Synthesis of the Compounds {#sec3dot2-molecules-25-03376}
-------------------------------

*Synthesis of the organic ligands*: The compounds \[(2-pyridyl)-2-ethyl)-(3,4-dimethoxy)-2-methylpyridyl\]methylamine (L^1^) and \[(2-pyridyl)-2-ethyl)-(3,4-dimethoxy)-2-methylpyridyl\]-methylamine (L^2^) \[[@B59-molecules-25-03376]\], \[bis(3,5-dimethyl-ethyl-pyrazol-1*H*-1-yl)-(3,4-dimethoxy-2-methylpyridyl)\]amine (L^3^) \[[@B60-molecules-25-03376]\], \[bis(2-methylpyridyl)-(3,4-dimethoxy-2-methylpyridyl)\]-amine, (L^4^) \[[@B8-molecules-25-03376]\] and tris(3,5-dimethyl-ethyl-1*H*-pyrazol-1-yl)amine (tedmpza) \[[@B61-molecules-25-03376],[@B62-molecules-25-03376]\] were prepared and characterized according to the published procedures.

*Synthesis of \[Cu(L^1^)(NCS)~2~\]* (**1**): To a mixture containing \[(2-pyridyl)-2-ethyl)-(3,4-dimethoxy)-2-methylpyridyl\]methylamine, L^1^ (0.145 g, 0.50 mmol) and Cu(ClO~4~)~2~·6H~2~O (0.190 g, 0.5 mmol) or Cu(NO~3~)~2~·3H~2~O (0.122 g, 0.50 mmol) dissolved in MeOH (20 mL) NH~4~NCS (0.076 g, 1.0 mmol) was added. The resulting green solution was heated for 5 min, filtered through celite and then allowed to stand at room temperature. After four days, the precipitate formed was collected by filtration and recrystallized from CH~3~CN to afford green single crystals suitable for X-ray analysis (yield: 0.215 g, 92%). Characterization: Anal. Calcd. for C~18~H~21~CuN~5~O~2~S~2~ (467.06 g/mol): C, 46.29; H, 4.53; N, 14.99. Found: C, 46.49; H, 4.47; N, 15.00%. Selected IR bands (ATR, cm^−1^): 2997 (vw), 2931 (vw), 2879 (vw), 2835 (vw) ν(C-H); 2055 (vs) ν~as~(N≡C) (NCS^−^); 1608 (s), 1496 (s), 1444 (s), 1362 (m), 1304 (s), 1231 (s), 1172 (m), 1069 (s), 1000 (s), 902 (m), 820 (s), 787 (m), 769 (vs), 733 (s). UV-vis (CH~3~CN), λ~max~, nm (ε~max~, cm^−1^ M^−1^): 385 (1180), 676 (190). Λ~M~ (CH~3~CN) = 9 Ω^−1^·cm^2^·mol^−1^.

*Synthesis of \[Cu(L^2^)(NCS)~2~\]* (**2**): To a mixture containing \[(2-pyridyl)-2-ethyl)-(3,5-dimethyl-4-methoxy)-2-methylpyridyl\]methylamine, L^2^ (0.140 g, 0.50 mmol) and Cu(ClO~4~)~2~·6H~2~O (0.190 g, 0.5 mmol) dissolved in MeOH (20 mL) NH~4~NCS (0.076 g, 1.0 mmol) was added. The resulting green solution was heated for 5 min, filtered and allowed to crystallize at room temperature. After two days, the produced precipitate was collected by filtration and recrystallized from CH~3~CN to afford green single crystals suitable for X-ray analysis (yield: 0.178 g, 77%). Characterization: Anal. Calc. for C~19~H~23~CuN~5~OS~2~ (465.09 g/mol): C, 49.07; H, 4.08; N, 15.06. Found: C, 49.26; H, 4.99; N, 15.13%. Selected IR bands (KBr, cm^−1^): 3003 (vw), 2919 (vw), 2872 (vw), ν(C-H); 2054 (vs) ν~as~(N≡C) (NCS^−^); 1606 (m), 1489 (m), 1475 (m), 1442 (m), 1268 (m), 1110 (m), 1012 (m), 999 (m), 904 (w), 880 (w), 769 (vs). UV-vis (CH~3~CN): λ~max~, nm (ε~max~, cm^−1^ M^−1^): 388 (1214), 676 (196). Λ~M~ (CH~3~CN) = 11 Ω^−1^·cm^2^·mol^−1^.

*Synthesis of \[Cu(isp~3~tren)(N~3~)\]ClO~4~* (**3**): To a mixture containing of Cu(ClO~4~)~2~·6H~2~O (0.190 g, 0.5 mmol) and tris(2-isopropylamino)ethyl)amine dissolved in 10 mL MeOH), an aqueous solution of NaN~3~ (0.033 g, 0.5 mmol in 5 mL H~2~O) was added dropwise. The resulting green solution was heated for 5 min, filtered through celite and allowed to stand at room temperature. After 3 days, the shiny green crystals which separated were collected by filtration, washed with propan-2-ol, ether and dried in air (overall yield: 0.210 g, 88%). Characterization: Anal. Calcd. for C~15~H~36~ClCuN~7~O~4~ (MM = 477.49 g/mol): C, 37.73; H, 7.60; N, 20.53%. Found: C, 37.80; H, 7.69; N, 20.64%. Selected IR bands (ATR, cm^−1^): 3269 (m), 3215 (m) ν(N-H); 2974 (w), 2879 (w) ν(C-H); 2055 (vs) ν~as~(N~3~); 1067 (vs) ν(Cl-O) (ClO~4~^−^). UV-vis in CH~3~CN: λ~max~ in nm (ε~max~, M^−1^cm^−1^): 695 (364, vbr), 870 (397, b). Λ~M~ (CH~3~CN) = 157 Ω^−1^·cm^2^·mol^−1^.

*Synthesis of \[Cu(isp~3~tren)(dca)\]ClO~4~* (**4**): The complex was isolated as tiny blue single crystals after two days using a procedure similar to that described for complex **3**, except Nadca was used instead of sodium azide (overall yield: 0.196 g, 78%). Characterization: Anal. Calcd. for C~17~H~36~ClCuN~7~O~4~ (MM = 501.51 g/mol): C, 40.71; H, 7.24; N, 19.55%. Found: C, 40.04; H, 7.32; N, 19.76%. Selected IR bands (ATR, cm^−1^): 3263 (w), 3228 (m) ν(N-H); 2988 (m), 2942 (m), 2885 (m) ν(C-H); 2301 (s), 2238 (s), 2172 (vs) ν~as~(N≡C) (dca); 1100 (vs, b) ν(Cl-O) (ClO~4~^−^). UV-vis in CH~3~CN: λ~max~ in nm (ε~max~, M^−1^cm^−1^): \~660 (sh), 837 (397, br). Λ~M~ (CH~3~CN) = 163 Ω^−1^·cm^2^·mol^−1^.

*Synthesis of \[Cu(L^3^)(NCS)\]ClO~4~* (**5**): To a mixture containing Cu(ClO~4~)~2~·6H~2~O (0.190 g, 0.50 mmol) and \[bis(3,5-dimethyl-ethyl-pyrazol-1*H*-1-yl)-(3,4-dimethoxy-2-methylpyridyl)\]amine, L^3^ (0.206 g, 0.50 mmol) dissolved in MeOH (20 mL), NH~4~NCS (0.038 g, 0.50 mmol) was added. The dark green solution was heated to boiling and filtered while hot through celite. After 2 h, the resulting green precipitate, which separated was collected by filtration, washed with propan-2-ol, ether and dried in air (yield: 0.30 g, 95%). Recrystallization of the product from H~2~O afforded medium spring green single crystals suitable for X-ray analysis. Characterization: Anal. Calcd. for C~23~H~32~ClCuN~7~O~6~S (MM = 633.61 g/mol): C, 43.60; H, 5.09; N, 15.47%. Found: C, 43.81; H, 5.06; N, 15.65%. Selected IR bands (ATR, cm^−1^): 3121 (w), 3089 (w), 2935 (w), 2844 (w) ν(C-H); 2091 (s) ν~as~(N≡C) (NCS^−^); 1604 (m), 1552 (m), 1502 (m), 1438 (m), 1309 (s), 1236 (w); 1073 (vs) ν(Cl-O) (ClO~4~^−^). UV-vis (CH~3~CN): λ~max~ in nm (ε~max~, M^−1^cm^−1^): 387 (1020), \~630 (sh), \~940 (76). Λ~M~ (CH~3~CN) = 149 Ω^−1^·cm^2^·mol^−1^.

*Synthesis of \[Cu(tedmpza)(dca)\]ClO~4~·0.*67H~2~O (**6**): A mixture of Cu(ClO~4~)~2~·6H~2~O (0.190 g, 0.50 mmol) and tris\[(3,5-dimethy-1*H*-pyrazol-yl)ethyl\]amine (tedmpza) dissolved in MeOH (20 mL) was treated with an aqueous solution containing Nadca (0.045 g, 0.50 mmol in 10 mL H~2~O). This was followed by heating for 10 min, filtration through celite and the solution was allowed to stand at room temperature. The bluish green crystalline compound, which was isolated after four days (yield: 0.185 g, 60%) was recrystallized from CH~3~OH to afford shiny bluish green single crystals suitable for X-ray analysis. Characterization: Anal. Calcd. for C~23~H~34.34~ClCuN~10~O~4.67~ (MM = 624.64 g/mol): C, 44.22; H, 5.54; N, 22.42%. Found: C, 44.42; H, 5.56; N, 22.48%. Selected IR bands (ATR, cm^−1^): 3448 (w) ν(O-H); 3137 (vw), 2926 (w) ν(C-H); 2347 (w), 2270 (w), 2203 (s) ν~as~(N-C) (dca); 1629 (w), 1552 (s), 1465 (m), 1424 (m), 1390 (m), 1331 (w) (pyrazolyl ring); 1091 (vs) ν(Cl-O) (ClO~4~^−^). UV-vis in CH~3~CN: λ~max~ in nm (ε~max~, M^−1^cm^−1^): 387 (960), \~730 (90, sh), \~940 (110, br). Λ~M~ (CH~3~CN) = 147 Ω^−1^·cm^2^·mol^−1^.

*Synthesis of \[Cu(L^4^)(dca)\](ClO~4~)·2H~2~O* (**7**): This was synthesized as described above for **6** except \[bis(2-methylpyridyl)-(3,4-dimethoxy-2-methylpyridyl)\]amine, L^4^ was used instead of tedmpza. The complex was isolated as bluish green crystalline compound after 2 days (overall yield: 0.220 g, 71%). Characterization: Anal. Calcd. for C~22~H~26~ClCuN~7~O~8~ (MM = 615.48 g/mol): C, 42.93; H, 4.26; N, 15.93%. Found: C, 42.80; H, 4.14; N, 15.93%. Selected IR bands (ATR, cm^−1^): 3435 (s,b), ν(O-H); 3076 (w), 2946 (w), 2848 (w) ν(C-H); 2300 (m), 2236 (s), 2176 (vs), 2137 (vs) ν~as~(N≡C) (dca); 1606 (s), 1501 (m), 1439 (m), 1366 (m), 1308 (m); 1090 (vs), 1067 (vs) ν(O-Cl) (ClO~4~^−^); 843 (w), 769 (m), 625 (m). UV-vis in CH~3~CN: λ~max~ in nm (ε~max~, M^−1^cm^−1^): 350 (923), \~665 (sh), 880 (256, br). Λ~M~ (CH~3~CN) = 148 Ω^−1^·cm^2^·mol^−1^.

3.3. X-ray Crystal Structure Analysis {#sec3dot3-molecules-25-03376}
-------------------------------------

Suitable single crystals of **1**--**6** were carefully selected under polarizing microscope and mounted on a goniometer head. A Bruker-AXS APEX II CCD diffractometer (Karlsruhe, Germany) operating with Mo-Kα radiation (λ = 0.71073 Å) at 100(2) K was used for single crystal data collection. In [Table 4](#molecules-25-03376-t004){ref-type="table"} relevant crystallographic data together with some features of the structure refinements are summarized. APEX and the SADABS computer programs \[[@B63-molecules-25-03376],[@B64-molecules-25-03376],[@B65-molecules-25-03376]\] were used for data processing, LP and absorption corrections. The SHELX \[[@B66-molecules-25-03376],[@B67-molecules-25-03376]\] program library was used for structure solution (direct methods) and refinement (full-matrix least-squares methods with F^2^ data). Non-hydrogen atoms were refined with anisotropic displacement parameters, while the hydrogen atoms were located from difference Fourier maps, and included in the refinements with isotropic displacement factors. HFIX geometrical constraints were applied for H atoms with parent C atoms. Additional computer programs: Mercury and PLATON \[[@B68-molecules-25-03376],[@B69-molecules-25-03376]\].

The structure **3** crystallizes in chiral space group P2~1~2~1~2~1~ includes only a single ligand enantiomer (R at each chiral N) and Flack parameter is 0.022(8). In structure of **5** a void centered at position 0.393, 0.568, 0.914 is separated by 3.22 Å from O2 acceptor atom. Its size of 37 Å^3^ corresponds to volume of one water molecule. No SQUEEZE treatment was applied. In case of **4** low but still acceptable crystal quality causes R~int~ of 0.141 and poor data/parameter ratio of 9.94.

4. Conclusions {#sec4-molecules-25-03376}
==============

Two series of geometrical five-coordinated pseudohalido-Cu(II) complexes were separated and structurally characterized: distorted square pyramidal: \[Cu(L^1^)(NCS)~2~\] (**1**), \[Cu(L^2^)(NCS)~2~\] (**2**), and \[Cu(L^3^)(NCS)\]ClO~4~ (**5**), and distorted trigonal bipyramidal: \[Cu(isp~3~tren)(N~3~)\]ClO~4~ (**3**), \[Cu(isp~3~tren)(dca)\]ClO~4~ (**4**), and \[Cu(tedmpza)(dca)\]ClO~4~∙0.67H~2~O (**6**). The geometrical identities of the complexes were also determined in solution and results are compared to other related reported compounds as well as to those derived from halido-Cu complexes with similar stereochemistry. In the pseudohalido complexes the consistency between the molecular and the assigned structures in solution was excellent ([Table 1](#molecules-25-03376-t001){ref-type="table"} and [Table 2](#molecules-25-03376-t002){ref-type="table"}) indicating we can rely with confidence that the molecular geometrical structure, which was determined in the solid state is retained in solution. On the other hand, in the five-coordinated halido-Cu(II) complexes the picture was a little bit complicated as it was turned out that the molecular structure geometries, sometimes do not persist in solutions and may stereochemically change and/or hydrolyzed as this was observed in \[Cu(6-MeTPA)Cl\]^+^ ([Table 3](#molecules-25-03376-t003){ref-type="table"}: **42**, **43**) and \[Cu(BPQA)Cl\]^+^ (**51** and **52**) \[[@B8-molecules-25-03376],[@B55-molecules-25-03376]\] and in the dist. SP series \[Cu(L^9^)Cl~2~\] (**61**), \[Cu(L^10^)(H~2~O)(Cl)~2~\] (**62**), and \[Cu(L^11^)(Br)~2~\] (**63**) \[[@B49-molecules-25-03376],[@B50-molecules-25-03376],[@B51-molecules-25-03376]\]. This result is important because five-coordinated halido-Cu(II) complexes, which are constructed from *N*-donor coligands are widely used as potential anticancer agents and to mimic biological systems \[[@B3-molecules-25-03376],[@B4-molecules-25-03376],[@B5-molecules-25-03376],[@B6-molecules-25-03376],[@B7-molecules-25-03376],[@B8-molecules-25-03376],[@B44-molecules-25-03376],[@B49-molecules-25-03376],[@B50-molecules-25-03376],[@B51-molecules-25-03376],[@B52-molecules-25-03376]\] and under these conditions the geometry and possibly the identity of the reactive species could be different from the originally isolated solid \[[@B5-molecules-25-03376],[@B6-molecules-25-03376],[@B7-molecules-25-03376],[@B8-molecules-25-03376],[@B44-molecules-25-03376],[@B49-molecules-25-03376],[@B50-molecules-25-03376],[@B51-molecules-25-03376],[@B52-molecules-25-03376]\]. In these cases, results in solutions must be handled with great care and we cannot rely with confidence on molecular structure determination to assign the structures in solutions.

To account for why a stereospecific geometry is adopted by a given five-coordinated Cu(II) compound (TBP vs. SP), number of parameters including chelate ring size, nature and steric environment imposed in the coligand's skeleton were addressed \[[@B22-molecules-25-03376],[@B23-molecules-25-03376],[@B24-molecules-25-03376]\]. In general, TBP structures are dominating in the solid state when the central Cu^2+^ ion is coordinated to tripod tetradentate ligands containing only five-membered chelate rings ([Table 1](#molecules-25-03376-t001){ref-type="table"} and [Table 3](#molecules-25-03376-t003){ref-type="table"}: **3**, **4**, **20**--**22**, **36**, **37**, **39**--**41**, **54**, **56**--**60**) \[[@B8-molecules-25-03376],[@B27-molecules-25-03376],[@B28-molecules-25-03376],[@B29-molecules-25-03376],[@B41-molecules-25-03376],[@B52-molecules-25-03376],[@B53-molecules-25-03376],[@B54-molecules-25-03376]\]. Also, the tendency for stabilization of SP geometry is enhanced (**18**, **30**--**32**, **47**--**50**) \[[@B23-molecules-25-03376],[@B30-molecules-25-03376],[@B43-molecules-25-03376],[@B48-molecules-25-03376],[@B56-molecules-25-03376],[@B57-molecules-25-03376]\] as the chelate ring sizes are increased to six-membered through insertion of CH~2~ group(s) into the ethylenic tripod arms. Interestingly, this analysis was proved to be universal in other five-coordinated complex ions such \[Cu(tren)(NH~3~)\]^2+^, \[Cu(Me~3~tren)(NCCH~3~)\]^2+^, \[Cu(TPA)(H~2~O)\]^2+^ and \[Cu(233)(NH~3~)\]^2+^ (233 = *N*-(2-aminoethyl)-*N*,*N*-bis(3-aminopropyl)amine), where the first three complexes were displaying distorted TBP geometry, whereas the latter one exhibits distorted SP geometry \[[@B55-molecules-25-03376],[@B70-molecules-25-03376],[@B71-molecules-25-03376],[@B72-molecules-25-03376]\]. The tendency for SP structures was also observed when CH~3~ groups were introduced at the 6th positions of the pyridyl arms in TPA or when one of the pyridyl groups was replaced with quinolyl groups (**42**, **43**, **45**, **52**) \[[@B8-molecules-25-03376],[@B56-molecules-25-03376]\]. Distorted SP environment was clearly dominating in all complexes derived from tridentate ligands regardless the chelate ring sizes (**1**, **2**, **8**--**16**, **30**) \[[@B22-molecules-25-03376],[@B23-molecules-25-03376],[@B24-molecules-25-03376],[@B40-molecules-25-03376],[@B42-molecules-25-03376],[@B43-molecules-25-03376]\], the macrocyclic complex \[Cu(cyclen-tpam)(NCS)\]ClO~4~·3H~2~O (**19**) \[[@B23-molecules-25-03376]\] as well as in \[Cu(Medpt)(ONO)(H~2~O)\]^+^ (τ = 0.03) and \[Cu(dien)(ONO)\]^+^ (τ = 0.13), where Medpt = 3,3′-diamino-*N*-methyldipropylamine and dien = diethylenetriamine \[[@B73-molecules-25-03376]\]. However, still some few contradictions exist in the geometrical behaviors of the SP \[Cu(tedmpza)(N~3~)\]ClO~4~ (**31**) \[[@B23-molecules-25-03376]\] and its corresponding distorted TBP structure \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O (**6**), which was expected to display SP geometry based on the previous analysis as well as in \[Cu(tepza)(NCS)\]ClO~4~ (**17**), which exhibits intermediate geometry and the TBP \[Cu(tepza)(dca)\]ClO~4~ (**38**) \[[@B25-molecules-25-03376]\], where both were predicted to display distorted SP geometry.
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The following are available online. CDCC 2008941-2008946 contains the supplementary crystallographic data for **1**--**6**, respectively. These data can be obtained free of charge via [http//www.ccdc.cam.ac.uk/conts/retrieving.html](http//www.ccdc.cam.ac.uk/conts/retrieving.html), or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; or e-mail: [deposit\@ccdc cam.ac.uk](mailto:deposit@ccdc cam.ac.uk). Selected bond lengths (Å) and angles (°) for the compounds under investigation are given in Tables S1--S3 and their corresponding packing views are shown in Figures S1--S6 for **1**--**6** coordination compounds, respectively. Coordination figures of Cu1 and Cu3 of **6** are given in Figures S7 and S8, respectively. The UV-vis spectra of the seven complexes under investigation are given in Figures S9--S15. Possible hydrogen bonds for compounds **1**--**6** are shown in Table S4.
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![Structure formulas of some *N*-donor ligands used in this study. Tris(2-pyridylmethyl)amine (TPA) was illustrated in the scheme for comparison with other derivatives of the compound.](molecules-25-03376-sch001){#molecules-25-03376-sch001}

![Perspective views of **1** (**left**), **2** (**center**) and complex cation of **5** (**right**). θ and ϕ bond angles (°) used for calculation of τ-values: **1**: N3-Cu-N5 167.20(3); N1-Cu-N4 162.13(9); **2**: N3-Cu-N5 168.4(3), N2-Cu-N4 160.3(3); and **5**: N6-Cu-N7 163.94(12), N1-Cu-N2 162.46(12).](molecules-25-03376-g001){#molecules-25-03376-f001}

![Perspective views of complex cations of **3** (**left**), **4** (**center**), and **6** (**right**). θ and ϕ bond (°) used for calculation of τ-values: **3**: N5-Cu1-N1 179.28(7); N2-Cu1-N3 132.54(6); **4**: N5-Cu1-N1 176.21(14), N2-Cu1-N4 129.85(14); **6**: N1-Cu1-N8 176.0(2), N3-Cu1-N7 128.2(2); N11-Cu2-N18 178.4(2), N15-Cu2-N17 125.3(2); and N21-Cu3-N28 176.7(2), N23-Cu3-N27 127.8(2).](molecules-25-03376-g002){#molecules-25-03376-f002}

![Topological transformation between square pyramidal (SP) and trigonal bipyramidal (TBP) geometries.](molecules-25-03376-g003){#molecules-25-03376-f003}

molecules-25-03376-t001_Table 1

###### 

Geometry and distortion parameter (τ) in mononuclear five-coordinated pseudohalido-copper(II) complexes derived from *N*-donor ligands in the solid states ^a^.

  Complex                                    τ Value    Geometry ^b^                   Ref.                             
  ------------------------------------------ ---------- ------------------------------ -------------------------------- -------------------------------
  \[Cu(L^1^)(NCS)~2~\]                       (**1**)    0.08                           dist. SP                         This work
  \[Cu(L^2^)(NCS)~2~\]                       (**2**)    0.14                           dist. SP                         This work
  \[Cu(bdmpzpy)(NCS)~2~\]                    (**8**)    0.25                           dist. SP                         \[[@B23-molecules-25-03376]\]
  \[Cu(Mebedmpza)(NCS)~2~\]                  (**9**)    0.06                           dist. SP                         \[[@B22-molecules-25-03376]\]
  \[Cu(Bzbedmpza)(NCS)~2~\]                  (**10**)   0.26                           dist. SP                         \[[@B22-molecules-25-03376]\]
  \[Cu(DPA)(NCS)(ClO~4~)\]                   (**11**)   0.21                           dist. SP                         \[[@B23-molecules-25-03376]\]
  \[Cu(mpipy)(NCS)~2~\]                      (**12**)   0.11                           dist. SP                         \[[@B42-molecules-25-03376]\]
  \[Cu(mpiq)(NCS)~2~\]                       (**13**)   0.33                           dist. SP                         \[[@B42-molecules-25-03376]\]
  \[Cu(pzdepy)(NCS)\]ClO~4~                  (**14**)   0.11                           dist. SP                         \[[@B43-molecules-25-03376]\]
  \[Cu(Me~3~dpt)(NCS)~2~\] ^c^               (**15**)   0.37, 0.49                     dist. SP, intermed.              \[[@B40-molecules-25-03376]\]
  \[Cu(bedmpza)(NCS)~2~\] ^c^                (**16**)   0.24, 0.46                     dist. SP, intermed.              \[[@B24-molecules-25-03376]\]
  \[Cu(tepza)(NCS)\]ClO~4~                   (**17**)   0.47                           Intermed.                        \[[@B25-molecules-25-03376]\]
  \[Cu(bdmpe)(NCS)\]ClO~4~                   (**18**)   0.17                           dist. SP                         \[[@B30-molecules-25-03376]\]
  \[Cu(L^3^)(NCS)\]ClO~4~                    (**5**)    0.02                           SP                               This work
  \[Cu(cyclen-tpam)(NCS)\]ClO~4~·3H~2~O      (**19**)   0.00                           SP                               \[[@B23-molecules-25-03376]\]
  \[Cu(L^5^)(NCS)\]ClO~4~                    (**20**)   0.43                           dist. SP                         \[[@B44-molecules-25-03376]\]
  \[Cu(L^5^)(N~3~)\]ClO~4~ ^c^               (**21**)   0.57, 0.65, 0.69               dist. TBP                        \[[@B44-molecules-25-03376]\]
  \[Cu(dpq)~2~(N~3~)\]ClO~4~                 (**22**)   0.22                           dist. SP                         \[[@B45-molecules-25-03376]\]
  \[Cu(pbpd)(N~3~)\]PF~6~                    (**23**)   0.60                           dist. SP                         \[[@B46-molecules-25-03376]\]
  \[Cu(pfbd)(N~3~)\]ClO~4~                   (**24**)   0.50                           Intermed.                        \[[@B46-molecules-25-03376]\]
  \[Cu(Me~3~tren)(N~3~)\]ClO~4~              (**25**)   0.80                           dist. TBP                        \[[@B29-molecules-25-03376]\]
  \[Cu(isp~3~tren)(N~3~)\]ClO~4~             (**3**)    0.78                           dist. TBP                        This work
  \[Cu(pdpa)(N~3~)\]ClO~4~                   (**26**)   0.60                           dist. TBP                        \[[@B29-molecules-25-03376]\]
  \[Cu(TPA)(N~3~)\]ClO~4~                    (**27**)   0.91                           dist. TBP                        \[[@B41-molecules-25-03376]\]
  \[Cu(BA)(N~3~)\]ClO~4~                     (**28**)   0.65                           dist. TBP                        \[[@B47-molecules-25-03376]\]
  \[Cu(F~5~BA)(N~3~)\]CF~3~SO~3~ ^c,d^       (**29**)   0.73; 0.68; 0.50; 0.61; 0.31   dist. TBP, dist. SP, Intermed.   \[[@B47-molecules-25-03376]\]
  \[Cu(pmap)(N~3~)\]ClO~4~                   (**30**)   0.10                           dist. SP                         \[[@B43-molecules-25-03376]\]
  \[Cu(tedmpza)(N~3~)\]ClO~4~                (**31**)   0.06                           dist. SP                         \[[@B23-molecules-25-03376]\]
  \[Cu(trpn)(N~3~)\]ClO~4~                   (**32**)   0.23                           dist. SP                         \[[@B48-molecules-25-03376]\]
  \[Cu(pmedien)(dca)~2~\]                    (**33**)   0.23                           dist. SP                         \[[@B29-molecules-25-03376]\]
  \[Cu(pzdepy)(dca)\]ClO~4~                  (**34**)   0.24                           dist. SP                         \[[@B28-molecules-25-03376]\]
  \[Cu(tren)(dca)\]ClO~4~                    (**35**)   0.87                           dist. TBP                        \[[@B27-molecules-25-03376]\]
  \[Cu(isp~3~tren)(dca)\]ClO~4~              (**4**)    0.77                           dist. TBP                        This work
  \[Cu(TPA)(dca)\]ClO~4~                     (**36**)   0.95                           dist. TBP                        \[[@B28-molecules-25-03376]\]
  \[Cu(tepa)(dca)\]ClO~4~                    (**37**)   0.21                           dist. SP                         \[[@B28-molecules-25-03376]\]
  \[Cu(tepza)(dca)\]ClO~4~ ^c^               (**38**)   0.61, 0.63                     dist. TBP                        \[[@B25-molecules-25-03376]\]
  \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O ^c^   (**6**)    0.79, 0.89, 0.82               dist. TBP                        This work

^a^ Ligand abbreviations: L^1^ = \[(2-pyridyl)-2-ethyl)-(3,4-dimethoxy)-2-methylpyridyl\]methylamine, L^2^ = \[(2-pyridyl)-2-ethyl)-(3,5-dimethyl-4-methoxy)-2-methylpyridyl\]methylamine, L^3^ = bis(2-ethyl-di(3,5-dimethyl-1*H*-pyrazol-1-yl)-\[2-(3,4-dimethoxypyridylmethyl)\]amine, L^4^ = bis(2-methyl-pyridyl)-\[2-(3,4-dimethoxypyridyl-methyl)\]amine, L^5^ = L \[*N*,*N*′-bis(1-pyridin-2-yl-ethylidene)-2,2-dimethylpropane-1,3-diamine, bedmpza = bis\[2-(di-2,5-dimethyl-1-pyrazolyl)-ethyl)\]amine, Mebedmpza = *N*-methyl-bis(3,5-dimethyl-2-(pyrazol-1*H*-yl)ethyl)amine, Bzbedmpza = *N*-benzyl-bis(3,5-dimethyl-2-(pyrazol-1*H*-yl)ethyl)amine, bdmpzpy = 2,6-bis\[(2,5-dimethyl-1*H*-pyrazol-1-yl)methyl\]pyridine, pmedien = *N*,*N*,*N*′,*N*″,*N*″-pentamethyldiethylenetriamine, DPA = bis(2-methylpyridyl)amine, Me~3~dpt = bis(*N*-methyl-3-aminpropyl)-methylamine, mpipy = *N*-methyl-*N*-(2-pyridylmethyl)piperazine, mpiq = *N*-methyl-*N*-(2-quinolyl-methyl)piperazine, pdpa = \[*N*-(3-aminopropyl)-*N*,*N*-bis(2-pyridylmethyl)\]amine, pzdepy = *N*,*N*-bis\[2-(2-pyridylethyl)\]-piperazine, tren = tris(2-aminoethyl)amine, Me~3~tren = tris(2-amino-*N*-methylethyl)amine, isp~3~tren = tris\[(2-isopropyl-amino)ethyl)\]amine, trpn = tris(3-aminopropyl)amine, TPA = tris\[(2-pyridyl)-methyl\]-amine, tepza = tris\[(2-ethyl-(1*H*-pyrazol-1-yl)\]amine, tedmpza = tris(3,5-dimethyl-ethyl-1*H*-pyrazol-1-yl)amine, pzdepy = 1,4-bis\[2-(2-pyridyl-ethyl)\]piperazine, bdmpe = *N*,*N*-bis((3,5-dimethyl-1*H*-pyrazol-yl)methyl)-2-(phenylthio)ethan-1-amine, cyclen-tpam = 1,4,7,10-tetrakis-(propionamide)-1,4,7,10-tetraazacyclododecane, dpq = dipyrido\[3,2-f: 20,30-h\]-quinoxaline, pbpd = *N*,*N*′-(bis(pyridin-2-yl)benzylidene)-propane-1,3-diamine, pfbd = *N*,*N*′-(bis(pyridin-2-yl)-formylidene)butane-1,4-diamine, BA = 6-((bis(pyridin-2-ylmethyl)amino)methyl)-*N*-((phenyl)-methyl)pyridin-2-amine, F~5~BA = 6-((bis(pyridin-2-ylmethyl)amino)methyl)-*N*-((perfluorophenyl)-methyl)pyridin-2-amine. ^b^ dist. = distorted. Intermed. = intermediate. ^c^ two or more molecules are in the unit cell. ^d^ complex is severely disorderd. *Note*: As in the title compounds **1**--**6** the CuN5 complexes all 10 valence angles of N-Cu-N have different values, the maximum angle is always the θ angle, and next largest angle is always the ϕ angle.

molecules-25-03376-t002_Table 2

###### 

The Visible spectral data in mononuclear five-coordinated pseudohalido-copper(II) complexes in solutions and the assigned predominant stereochemical geometry.

  Complex                                 Solvent    λ~max~, nm (ε~max~, M^−1^cm^−1^)   Predicted Geometry                Ref.          
  --------------------------------------- ---------- ---------------------------------- --------------------------------- ------------- -------------------------------
  \[Cu(L^1^)(NCS)~2~\]                    (**1**)    CH~3~CN                            676 (190)                         dist. SP      This work
  \[Cu(L^2^)(NCS)~2~\]                    (**2**)    CH~3~CN                            676 (196)                         dist. SP      This work
  \[Cu(bdmpzpy)(NCS)~2~\]                 (**8**)    CH~3~OH                            670 (sat)                         dist. SP      \[[@B23-molecules-25-03376]\]
  \[Cu(Mebedmpza)(NCS)~2~\]               (**9**)    CH~3~CN                            731 (155, br)                     dist. SP      \[[@B22-molecules-25-03376]\]
  \[Cu(Bzbedmpza)(NCS)~2~\]               (**10**)   CH~3~CN                            704 (155, br)                     dist. SP      \[[@B22-molecules-25-03376]\]
  \[Cu(mpipy)(NCS)~2~\]                   (**12**)   CH~3~CN                            729 (288)                         dist. SP      \[[@B42-molecules-25-03376]\]
  \[Cu(mpiq)(NCS)~2~\]                    (**13**)   CH~3~CN                            775 (230)                         dist. SP      \[[@B42-molecules-25-03376]\]
  \[Cu(pzdepy)(NCS)\]ClO~4~               (**14**)   H~2~O                              591 (304)                         dist. SP      \[[@B43-molecules-25-03376]\]
  \[Cu(Me~3~dpt)(NCS)~2~\]                (**15**)   CH~3~CN                            686 (204), 932 (141)              dist. SP      \[[@B40-molecules-25-03376]\]
  \[Cu(bedmpza)(NCS)~2~\]                 (**16**)   CH~3~CN                            725 (149)                         dist. SP      \[[@B24-molecules-25-03376]\]
  \[Cu(tepza)(NCS)\]ClO~4~                (**17**)   CH~3~CN                            704 (174, br)                     dist. SP      \[[@B25-molecules-25-03376]\]
  \[Cu(bdmpe)(NCS)\]ClO~4~                (**18**)   CH~3~CN                            663 (174)                         dist. SP      \[[@B30-molecules-25-03376]\]
  \[Cu(L^3^)(NCS)\]ClO~4~                 (**5**)    CH~3~CN                            \~630 (sh), \~940 (76)            dist. SP      This work
  \[Cu(cyclen-tpam)(NCS)\]ClO~4~·3H~2~O   (**19**)   H~2~O                              623 (435)                         dist. SP      \[[@B23-molecules-25-03376]\]
  \[Cu(L^5^)(NCS)\]ClO~4~                 (**20**)   CH~3~CN                            720 (203)                         dist. SP      \[[@B44-molecules-25-03376]\]
  \[Cu(L^5^)(N~3~)\]ClO~4~                (**21**)   CH~3~CN                            383 (155)                         dist. SP      \[[@B44-molecules-25-03376]\]
  \[Cu(dpq)~2~(N~3~)\]ClO~4~              (**22**)   DMSO                               680 (110), 1050 (sh)              dist. SP      \[[@B45-molecules-25-03376]\]
  \[Cu(pbpd)(N~3~)\]PF~6~                 (**23**)   MeOH                               718                               dist. SP      \[[@B46-molecules-25-03376]\]
  \[Cu(pfbd)(N~3~)\]ClO~4~                (**24**)   MeOH                               720                               dist. SP      \[[@B46-molecules-25-03376]\]
  \[Cu(Me~3~tren)(N~3~)\]ClO~4~           (**25**)   H~2~O                              665 (\~162), 855 (300, br)        dist. TBP     \[[@B29-molecules-25-03376]\]
  \[Cu(isp~3~tren)(N~3~)\]ClO~4~          (**3**)    CH~3~CN                            695 (364, br), 870 (397, br)      dist. TBP     This work
  \[Cu(pdpa)(N~3~)\]ClO~4~                (**26**)   H~2~O                              656 (132, sh), 852 (200)          dist. TBP     \[[@B29-molecules-25-03376]\]
  \[Cu(TPA)(N~3~)\]ClO~4~                 (**27**)   CH~3~OH                            \~650, 836 (201)                  dist. TBP     \[[@B41-molecules-25-03376]\]
  \[Cu(BA)(N~3~)\]ClO~4~                  (**28**)   CH~3~CN                            650, \~880                        \~dist. TBP   \[[@B47-molecules-25-03376]\]
  \[Cu(F~5~BA)(N~3~)\]ClO~4~              (**29**)   CH~3~CN                            655, \~870                        \~dist. TBP   \[[@B47-molecules-25-03376]\]
  \[Cu(pmap)(N~3~)\]ClO~4~                (**30**)   H~2~O                              634 (268)                         dist. SP      \[[@B43-molecules-25-03376]\]
  \[Cu(tedmpza)(N~3~)\]ClO~4~             (**31**)   CH~3~CN                            713 (354, br)                     dist. SP      \[[@B23-molecules-25-03376]\]
  \[Cu(trpn)(N~3~)\]ClO~4~                (**32**)   H~2~O                              685 (118), 900 (sh)               dist. SP      \[[@B48-molecules-25-03376]\]
  \[Cu(trpn)(N~3~)\]ClO~4~                (**32**)   DMSO                               670 (275), 920 (sh)               dist. SP      \[[@B48-molecules-25-03376]\]
  \[Cu(pmedien)(dca)~2~\]                 (**33**)   H~2~O                              638 (265)                         dist. SP      \[[@B29-molecules-25-03376]\]
  \[Cu(pzdepy)(dca)\]ClO~4~               (**34**)   H~2~O                              591 (304)                         dist. SP      \[[@B28-molecules-25-03376]\]
  \[Cu(tren)(dca)\]ClO~4~                 (**35**)   CH~3~CN                            665, 828                          dist. TBP     \[[@B27-molecules-25-03376]\]
  \[Cu(isp~3~tren)(dca)\]ClO~4~           (**4**)    CH~3~CN                            \~660 (sh), 837 (397, br)         dist. TBP     This work
  \[Cu(TPA)(dca)\]ClO~4~                  (**36**)   H~2~O                              \~650, 872 (239)                  dist. TBP     \[[@B28-molecules-25-03376]\]
  \[Cu(tepa)(dca)\]ClO~4~                 (**37**)   H~2~O                              650 (114), \~739 (sh)             dist. SP      \[[@B28-molecules-25-03376]\]
  \[Cu(tepa)(dca)\]ClO~4~                 (**37**)   CH~3~OH                            640 (187)                         dist. SP      \[[@B28-molecules-25-03376]\]
  \[Cu(tepa)(dca)\]ClO~4~                 (**37**)   CH~3~CN                            645 (217)                         dist. SP      \[[@B28-molecules-25-03376]\]
  \[Cu(tepa)(dca)\]ClO~4~                 (**37**)   CH~3~NO~2~                         640 (229)                         dist. SP      \[[@B28-molecules-25-03376]\]
  \[Cu(tepza)(dca)\]ClO~4~                (**38**)   H~2~O                              676 (93, br)                      dist. SP      \[[@B25-molecules-25-03376]\]
  \[Cu(tedmpza)(dca)\]ClO~4~·0.67H~2~O    (**6**)    CH~3~CN                            \~730 (90, sh), \~940 (110, br)   dist. TBP     This work
  \[Cu(L^4^)(dca)\](ClO~4~)·2H~2~O        (**7**)    CH~3~CN                            \~665 (sh), 880 (256, br)         dist. TBP     This work

molecules-25-03376-t003_Table 3

###### 

The molecular structure, the distortion index parameter (τ), the visible spectral absorption bands of mononuclear five-coordinated halido-Cu(II) complexes ^a^ in acetonitrile solutions and the assigned geometry.

  Complex                            τ Value    Geometry      λ~max~, nm (ε~max~, M^−1^cm^−1^)   Assigned Geometry                Ref.        
  ---------------------------------- ---------- ------------- ---------------------------------- -------------------------------- ----------- ---------------------------------------------------------
  \[Cu(TPA)Cl\]ClO~4~·½H~2~O ^b,c^   (**39**)   0.98, 0.94    TBP                                \~730 (sh), 950 (br)             dist TBP    \[[@B52-molecules-25-03376]\]
  \[Cu(TPA)Cl\]PF~6~                 (**40**)   ≈1.0          TBP                                962 (210), 632 (88, sh)          TBP         \[[@B53-molecules-25-03376],[@B54-molecules-25-03376]\]
  \[Cu(TPA)F\]PF~6~·CH~2~Cl~2~       (**41**)   0.91          dist. TBP                          710 (sh), 872                    dist. TBP   \[[@B54-molecules-25-03376]\]
  \[Cu(6-MeTPA)Cl\]PF~6~             (**42**)   0.12          dist. SP                           \~670 (sh), 885 (132, br)        dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(6-MeTPA)Cl\]ClO~4~ ^c^        (**43**)   0.16, 0.24    dist. SP                           \-                                           \[[@B55-molecules-25-03376]\]
  \[Cu(6-Me~2~TPA)Cl\]PF~6~          (**44**)   \-            \-                                 685 (148), \~860 (sh)            dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(6-Me~2~TPA)Cl\]ClO~4~         (**45**)   0.07          SP                                 \-                               \-          \[[@B55-molecules-25-03376]\]
  \[Cu(6-Me~3~TPA)Cl\]ClO~4~         (**46**)   0.43          Intermed.                          \-                               \-          \[[@B55-molecules-25-03376]\]
  \[Cu(pmea)Cl\]ClO~4~·H~2~O         (**47**)   ≈0            SP                                 \-                                           \[[@B56-molecules-25-03376]\]
  \[Cu(pmapCl\]ClO~4~                (**48**)   ≈0            SP                                 \-                                           \[[@B56-molecules-25-03376],[@B57-molecules-25-03376]\]
  \[Cu(pmap)Cl\]PF~6~·¼CH~2~Cl~2~    (**49**)   \-            dist. SP                           639 (192), 898 (sh, 23)          dist SP     \[[@B56-molecules-25-03376]\]
  \[Cu(tepa)Cl\]PF~6~                (**50**)   ≈0            SP                                 665 (200), 967 (48)              SP          \[[@B57-molecules-25-03376]\]
  \[Cu(BPQA)Cl\]ClO~4~               (**51**)   0.16          dist. SP                           \~640, 880 (151, br)             dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(BPQA)Cl\]PF~6~                (**52**)   0.13          dist. SP                           \~700 (sh), 900 (159, br)        dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(BQPA)Cl\]ClO~4~               (**53**)   \-            \-                                 730 (138, br), \~880 (143, br)   Intermed.   \[[@B8-molecules-25-03376]\]
  \[Cu(BQPA)Cl\]PF~6~                (**54**)   0.64          dist. TBP                          \~660 (sh), 880 (141, br)        dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(L^6^)Cl\]ClO~4~               (**55**)   \-            \-                                 \~725 (sh), 955 (221)            dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(L^6^)Cl\]PF~6~ ^c^            (**56**)   0.96 (mean)   TBP                                \~700, \~850 (sh), 970 (355)     dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(L^7^)Cl\]ClO~4~               (**57**)   0.86          dist. TBP                          \~715 (sh), 960 (230, br)        dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(L^8^)Cl\]ClO~4~               (**58**)   0.80          dist. TBP                          \~710, \~880 (sh), 970 (371)     dist TBP    \[[@B8-molecules-25-03376]\]
  \[Cu(Me~6~tren)Cl\]Cl              (**59**)   1.0           TBP                                938 (451)                        dist TBP    \[[@B58-molecules-25-03376]\]
  \[Cu(Me~6~tren)Br\]Br              (**60**)   1.0           TBP                                973 (426)                        dist TBP    \[[@B58-molecules-25-03376]\]
  \[Cu(L^9^)Cl~2~\] ^d^              (**61**)   0.11          dist. SP                           787 (280)                        dist. SP    \[[@B49-molecules-25-03376]\]
  \[Cu(L^10^)(H~2~O)(Cl)~2~\] ^e^    (**62**)   0.27          dist. SP                           463 (sh, 503), 806 (135)         dist. SP    \[[@B50-molecules-25-03376]\]
  \[Cu(L^11^)(Br)~2~\]               (**63**)   0.09          dist. SP                           \-                                           \[[@B51-molecules-25-03376]\]

^a^ TPA = tris\[(2-pyridyl)methyl\]amine, pmea = \[bis((2-pyridyl)methyl)-2-(2-pyridyl)-ethyl\]amine, pmpa = \[bis((2-(2-pyridyl)ethyl))-(2-pyridyl)-methyl\]amine, tepa = tris\[2-(2-pyridyl)ethyl\]amine, 6-MeTPA = ((6-methyl-2-pyridyl)methyl)bis(2-pyridylmethyl)amine, 6-Me~2~TPA = bis(6-methyl-2-pyridyl)methyl)-(2-pyridylmethyl)amine, BPQA = bis(2-pyridylmethyl)-(2-quinolylmethyl)amine and BQPA = bis(2-quinolylmethyl)-(2-pyridylmethyl)amine, L^6^ = \[(3,5-dimethyl-4-methoxy-2-pyridylmethyl)-bis(2-pyridyl-methyl)\]amine, L^7^ = \[(3,4-dimethoxy-2-pyridylmethyl)-bis(2-pyridylmethyl)\]amine, L^8^ =\[bis(3,5-dimethyl-4-methoxy-2-pyridylmethyl)-(2-pyridylmethyl)\]amine, Me~6~tren = tris\[2-(dimethylamino)ethyl\]-amine, L^9^ = benzyldipicolylamine; L^10^ = 2,9-di-methylphenanthroline; L^11^ = 2-(6-(pyridine-2-yl)-4-*p*-tolylpyridin-2-yl)pyridine. ^b^ measured in aqueous solution. ^c^ there are two more molecules in the unit cell. ^d^ measured in DMF. ^e^ measured in DMSO.

molecules-25-03376-t004_Table 4

###### 

Crystallographic data and processing parameters of **1**--**6**.

  Compound                    1                          2                         3
  --------------------------- -------------------------- ------------------------- ---------------------------------
  Empirical formula           C~18~H~21~CuN~5~O~2~S~2~   C~19~H~23~CuN~5~OS~2~     C~15~H~36~ClCuN~7~O~4~
  Formula mass                467.01                     465.09                    477.51
  System                      Monoclinic                 Monoclinic                Orthorhombic
  Space group                 P2~1~/c                    P2~1~/c                   P2~1~2~1~2~1~
  a (Å)                       9.9325(18)                 8.037(3)                  8.2797(3)
  b (Å)                       7.6958(14)                 28.198(9)                 10.3404(4)
  c (Å)                       26.491(5)                  9.219(3)                  25.1838(10)
  α (°)                       90                         90                        90
  β (°)                       95.923(3)                  93.416(5)                 90
  γ (°)                       90                         90                        90
  V (Å^3^)                    2014.8(6)                  2085.6(12)                2156.12(14)
  Z                           4                          4                         4
  T (K)                       100(2)                     100(2)                    100(2)
  μ (mm^−1^)                  1.316                      1.267                     1.173
  D~calc~ (Mg/m^3^)           1.540                      1.481                     1.471
  θ max (°)                   26.349                     26.395                    24.999
  Data collected              14,125                     12,796                    71,092
  Unique refl./R~int~         4099/0.0268                4193/0.1191               3756/0.0437
  Parameters/Restraints       256/0                      257/0                     260/0
  Goodness-of-Fit on F^2^     1.074                      1.123                     1.110
  R1/wR2 (all data)           0.0373/0.0956              0.0943/0.2051             0.0152/0.0388
  Residual extrema (e/Å^3^)   1.119/−0.465               1.215/−0.998              0.210/−0.150
  **Compound**                **4**                      **5**                     **6**
  Empirical formula           C~17~H~36~ClCuN~7~O~4~     C~23~H~32~ClCuN~7~O~6~S   C~69~H~103~Cl~3~Cu~3~N~30~O~14~
  Formula mass                501.53                     633.62                    1873.81
  System                      Orthorhombic               Monoclinic                Triclinic
  Space group                 Pbca                       P2~1~/c                   P1
  a (Å)                       20.0498(9)                 8.8023(7)                 9.9990(10)
  b (Å)                       15.1408(6)                 29.700(2)                 15.7623(17)
  c (Å)                       15.5606(7)                 11.2141(10)               15.9456(18)
  α (°)                       90                         90                        114.689(5)
  β (°)                       90                         93.260(4)                 100.284(5)
  γ (°)                       90                         90                        103.717(5)
  V (Å^3^)                    4723.7(4)                  2926.9(4)                 2105.8(4)
  Z                           8                          4                         1
  T (K)                       100(2)                     100(2)                    100(2)
  μ (mm^−1^)                  1.074                      0.958                     0.925
  D~calc~ (Mg/m^3^)           1.410                      1.438                     1.478
  θ max (°)                   24.997                     27.025                    28.276
  Data collected              102,653                    25,071                    93,026
  Unique refl./R~int~         4125/0.1406                6395/0.0647               17,329/0.0922
  Parameters/Restraints       415/0                      395/36                    1099/12
  Goodness-of-Fit on F^2^     1.106                      1.062                     1.044
  R1/wR2 (all data)           0.0422/0.1352              0.0542/0.1258             0.0549/0.1347
  Residual extrema (e/Å^3^)   1.180/−0.477               0.679/−0.526              1.249/−0.942
